Get the Stockscreener App
1.03
0.96%
-0.01
Enzo Biochem Inc stock is traded at $1.03, with a volume of 101.44K.
It is down -0.96% in the last 24 hours and down -9.65% over the past month.
Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. The company has one reportable segment, Products, which focuses on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins.
See More
Previous Close:
$1.04
Open:
$1.06
24h Volume:
101.44K
Relative Volume:
1.17
Market Cap:
$54.33M
Revenue:
$20.59M
Net Income/Loss:
$24.31M
P/E Ratio:
-1.0957
EPS:
-0.94
Net Cash Flow:
$-44.02M
1W Performance:
+4.35%
1M Performance:
-9.65%
6M Performance:
-3.74%
1Y Performance:
-17.60%
1-Day Range:
$1.02
$1.07
1-Week Range:
$0.9302
$1.07
52-Week Range:
$0.9302
$1.50
Enzo Biochem Inc Stock (ENZ) Company Profile
Name
Enzo Biochem Inc
Sector
Industry
Phone
(516) 755-5500
Address
60 EXECUTIVE BLVD, FARMINGDALE, NY
Compare ENZ with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ENZ
Enzo Biochem Inc
|
1.03 | 54.33M | 20.59M | 24.31M | -44.02M | -0.94 |
|
TMO
Thermo Fisher Scientific Inc
|
521.66 | 199.82B | 42.37B | 6.14B | 7.78B | 15.26 |
|
DHR
Danaher Corp
|
238.83 | 173.66B | 23.74B | 3.89B | 4.98B | 7.93 |
|
A
Agilent Technologies Inc
|
138.14 | 38.64B | 6.51B | 1.29B | 1.37B | 3.82 |
|
IQV
Iqvia Holdings Inc
|
201.43 | 36.52B | 15.32B | 1.41B | 1.96B | 5.95 |
|
IDXX
Idexx Laboratories Inc
|
421.76 | 34.55B | 3.84B | 866.24M | 792.60M | 9.80 |
Enzo Biochem Inc Stock (ENZ) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-18-11 | Reiterated | Rodman & Renshaw | Mkt Outperform |
| Sep-23-09 | Initiated | Rodman & Renshaw | Mkt Outperform |
| Sep-13-07 | Initiated | Lazard Capital | Buy |
Enzo Biochem Inc Stock (ENZ) Latest News
Enzo Biochem Appoints Jon Couchman to Board - TipRanks
Enzo Biochem (NYSE:ENZ) Now Covered by StockNews.com - MarketBeat
Enzo Biochem stock hits 52-week low at $0.99 amid market challenges By Investing.com - Investing.com South Africa
Enzo Biochem stock hits 52-week low at $0.99 amid market challenges - Investing.com Canada
Oxidative Stress Assay Market Geographical Segmentation, - openPR
Enzo Biochem (NYSE:ENZ) Now Covered by Analysts at StockNews.com - MarketBeat
We're Keeping An Eye On Enzo Biochem's (NYSE:ENZ) Cash Burn Rate - Yahoo Finance
Enzo Biochem Full Year 2024 Earnings: US$0.19 loss per share (vs US$0.51 loss in FY 2023) - Yahoo Finance UK
ENZ Stock Up Following FY24 Earnings Uptick, Gross Margin Expands - MSN
Enzo Biochem Reports Revenue Growth Despite Losses - TipRanks
Enzo Biochem (NYSE:ENZ) Shares Pass Above 200 Day Moving AverageShould You Sell? - MarketBeat
Enzo Biochem Reports Fourth Quarter and Fiscal Year 2024 Results and Announces Cash Dividend - The Manila Times
Enzo Biochem, Inc. Reports Earnings Results for the Full Year Ended July 31, 2024 - Marketscreener.com
Short Interest in Enzo Biochem, Inc. (NYSE:ENZ) Grows By 8.2% - MarketBeat
Biotech company settles for $4.5M after cybercriminals use decade-old password in massive data breach: NY AG - MSN
Difficult-to-Express Proteins Global Market Report 2024: Forecast And Share 2033 - WhaTech
Multiplex PCR Assays Market Forecast 2024: Innovations, Demand Drivers, and Emerging Technologies - WhaTech
Enzo Biochem (NYSE:ENZ) Coverage Initiated at StockNews.com - MarketBeat
Enzo Biochem (NYSE:ENZ) Stock Price Crosses Above Two Hundred Day Moving Average of $1.13 - MarketBeat
Enzo Biochem (NYSE:ENZ) Research Coverage Started at StockNews.com - MarketBeat
New York City Mayor Eric Adams Charged for Accepting Foreign Bribes - The National Law Review
Recombinant Proteins Market Size to Reach USD 5.0 Billion by 2032, at a CAGR of 7.6%SNS Insider - GlobeNewswire
Bio Lab Settles Conn. False-Claims Allegations For $1.73M - Law360
$1.7 Million Settlement Reached With Clinical Lab - Law.com
Connecticut Attorney General announces $1.7 million false claims settlement with Enzo Clinical Labs - MSN
Canada Pension Plan Investment Board Lowers Stock Position in Edwards Lifesciences Co. (NYSE:EW) - Defense World
First Eagle Investment Management LLC Boosts Holdings in Entegris, Inc. (NASDAQ:ENTG) - Defense World
Canada Pension Plan Investment Board Boosts Stake in Extra Space Storage Inc. (NYSE:EXR) - Defense World
Envestnet Asset Management Inc. Purchases 45,253 Shares of Extra Space Storage Inc. (NYSE:EXR) - Defense World
Enzo Biochem (NYSE:ENZ) Earns Hold Rating from Analysts at StockNews.com - MarketBeat
Granite Investment Partners LLC Lowers Holdings in Enovis Co. (NYSE:ENOV) - Defense World
Acadian Asset Management LLC Makes New $276,000 Investment in Entegris, Inc. (NASDAQ:ENTG) - Defense World
Enzo Biochem (NYSE:ENZ) Stock Passes Above 200-Day Moving Average of $1.14 - MarketBeat
AI is Redefining the Hepatitis B and C Diagnostics Market, Set to Grow by USD 3.02 Billion from 2024-2028 with Rising Demand for Molecular DiagnosticsTechnavio - The Malaysian Reserve
AI Is Redefining The Hepatitis B And C Diagnostics Market, Set To Grow By USD 3.02 Billion From 2024-2028 With Rising Demand For Molecular Diagnostics... - MENAFN.COM
Professional Diagnostics Market Giants Spending Is Going To Boom| Becton Dickinson (BD) , Enzo Biochem Inc - Newstrail
Edgewise Therapeutics Soars 50%: Key Reasons Behind the Surge - MarketBeat
Extra Space Storage Inc (NYSE:EXR) Raised By Jefferies - FXDailyReport.com
Ensysce Biosciences Submits Phase 3 Protocol to the FDA - StockTitan
India News | ⚡Kolkata-Based Company Ellenbarrie Industrial Gases Files IPO Papers - LatestLY
Immunoassay Market Trends, Outlook, Insights, Overview 2024-2033 - WhaTech
United States Pepsin Inhibitor Market By Application - Third Eye News
ENGAGE XR Posts Revenue Growth and Strategic Deals - TipRanks
Immunoassay Market Projected Growth Outlined by Insights, Competitive Analysis, Latest Trends, And Forecast... - WhaTech
In Vitro Toxicology Market Expansion: Key Research, Trends, and Strategies Powering Growth to $17.1 Billion - WhaTech
Bulgarian Academy of Sciences Issues Report on Results of Its In Vivo Testing of IPF as an Immunomodulator - AccessWire
Extra Storage rises on Jefferies upgrade - XM
Global Immunoassay Market Forthcoming Trends and Share Analysis by 2032 - 대구포스트
Cancer Profiling Market Growth Analysis, Industry Forecast To 2033 - WhaTech
Cardiac Biomarkers Testing Market Strategies to Increase Productivity by 2033 - Cauverynews
End Stage Renal Disease (ESRD) Drug Global Market Innovations Investigated by Size, Growth Demands, Forecas... - WhaTech
Enzo Biochem Inc Stock (ENZ) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.43%
0.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):